Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy

Malignant pleural mesothelioma (MPM) is a rare neoplasm, generally caused by asbestos exposure. This case details how a patient treated with nintedanib during the LUME‐Meso study was rechallenged with nintedanib. The findings highlight the benefit of nintedanib rechallenge and the potential use of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Grosso, Federica, Roveta, Annalisa, Gallizzi, Giulia, Belletti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186873/
https://www.ncbi.nlm.nih.gov/pubmed/30349716
http://dx.doi.org/10.1002/ccr3.1775
_version_ 1783362922971398144
author Grosso, Federica
Roveta, Annalisa
Gallizzi, Giulia
Belletti, Marco
author_facet Grosso, Federica
Roveta, Annalisa
Gallizzi, Giulia
Belletti, Marco
author_sort Grosso, Federica
collection PubMed
description Malignant pleural mesothelioma (MPM) is a rare neoplasm, generally caused by asbestos exposure. This case details how a patient treated with nintedanib during the LUME‐Meso study was rechallenged with nintedanib. The findings highlight the benefit of nintedanib rechallenge and the potential use of continuous anti‐angiogenic therapy in MPM treatment.
format Online
Article
Text
id pubmed-6186873
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61868732018-10-22 Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy Grosso, Federica Roveta, Annalisa Gallizzi, Giulia Belletti, Marco Clin Case Rep Case Reports Malignant pleural mesothelioma (MPM) is a rare neoplasm, generally caused by asbestos exposure. This case details how a patient treated with nintedanib during the LUME‐Meso study was rechallenged with nintedanib. The findings highlight the benefit of nintedanib rechallenge and the potential use of continuous anti‐angiogenic therapy in MPM treatment. John Wiley and Sons Inc. 2018-09-04 /pmc/articles/PMC6186873/ /pubmed/30349716 http://dx.doi.org/10.1002/ccr3.1775 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Grosso, Federica
Roveta, Annalisa
Gallizzi, Giulia
Belletti, Marco
Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
title Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
title_full Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
title_fullStr Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
title_full_unstemmed Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
title_short Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
title_sort management of recurrent pleural mesothelioma: successful rechallenge with nintedanib in combination with chemotherapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186873/
https://www.ncbi.nlm.nih.gov/pubmed/30349716
http://dx.doi.org/10.1002/ccr3.1775
work_keys_str_mv AT grossofederica managementofrecurrentpleuralmesotheliomasuccessfulrechallengewithnintedanibincombinationwithchemotherapy
AT rovetaannalisa managementofrecurrentpleuralmesotheliomasuccessfulrechallengewithnintedanibincombinationwithchemotherapy
AT gallizzigiulia managementofrecurrentpleuralmesotheliomasuccessfulrechallengewithnintedanibincombinationwithchemotherapy
AT bellettimarco managementofrecurrentpleuralmesotheliomasuccessfulrechallengewithnintedanibincombinationwithchemotherapy

Ejemplares similares